Human Aortic Endothelial Cells
Overview
Human Aortic Endothelial Cells (HAECs) are specialized cells lining the interior surface of the aorta, playing pivotal roles in vascular homeostasis, immune response, and barrier function. Isolated from human donors, these primary cells are indispensable for studying endothelial biology and pathologies like atherosclerosis and hypertension. HAECs are characterized by their cobblestone morphology in culture and expression of endothelial-specific markers such as von Willebrand Factor (vWF) and CD31. They are widely utilized in academic and pharmaceutical research due to their relevance to human physiology.
Key Features
HAECs retain critical in vivo functionalities, including nitric oxide production, adhesion molecule expression, and responsiveness to inflammatory cytokines. These features make them ideal for mechanistic studies of vascular diseases. Cultured HAECs require optimized conditions, including endothelial basal media supplemented with growth factors (e.g., VEGF, FGF) and extracellular matrix coatings (e.g., gelatin or fibronectin). Their shear stress sensitivity allows modeling of hemodynamic effects on endothelial behavior.
Application Areas
HAECs are central to cardiovascular research, particularly in investigating endothelial dysfunction, leukocyte adhesion, and thrombosis. They are also used in drug development to assess compound effects on vasodilation, inflammation, and oxidative stress. In regenerative medicine, HAECs contribute to tissue engineering of vascular grafts. Their ability to form tubular structures in vitro supports angiogenesis studies, aiding therapies for ischemic diseases.
Precautions
Handling HAECs demands strict aseptic techniques to prevent microbial contamination. Cells should be cultured at 37°C with 5% CO2 and monitored for morphological changes indicative of senescence or dedifferentiation. Avoid using high-passage cells (typically > P6) as they may lose functional properties. Quality control checks, including mycoplasma testing and marker validation, are essential for reproducible experiments.
B2B Procurement Guide
When sourcing HAECs, prioritize suppliers providing detailed donor profiles (age, sex, medical history) and certificates of analysis (viability, sterility, marker expression). Custom isolations from diseased donors (e.g., diabetic) may be available for specialized research. Bulk purchases for high-throughput screening may qualify for discounts. Consider cryopreserved vials for flexibility, ensuring thawing protocols are followed to maximize cell recovery.